Tag Archives: U.S.

Tremfya (guselkumab) Approved by U.S. Food and Drug Administration as the First Selective Interleukin (IL)-23 Inhibitor for Active Psoriatic Arthritis

Print this page HORSHAM, PA, July 14, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has approved Tremfya (guselkumab) for adult patients with active psoriatic arthritis (PsA), a chronic progressive disease characterized by painful joints and skin inflammation.[1],[2] Tremfya is the first treatment… Read More »

Dr. Scott Gottlieb estimates as many as 1 in 150 people in U.S. are infected with coronavirus

Dr. Scott Gottlieb told CNBC on Friday he believes there continues to be a significant number of unreported coronavirus cases in the U.S., suggesting as many as 1 in 150 people in the country could be infected.  “We must have well over 700,000 infections a day, even though we’re only diagnosing about 60,000,” Gottlieb said… Read More »

U.S. reports 30,000 daily coronavirus cases, highest number since May 1

The U.S reported some 30,000 new coronavirus cases on Friday, the highest number of daily infections recorded since May 1, according to data compiled by Johns Hopkins University. New cases across the country are surging faster than ever, especially in states in the South, West and Midwest. Officials are warning that some clusters of infections… Read More »

3 New U.S. Coronavirus Cases of Unknown Origin Reported; WHO Ups Risk Level to ‘Very High’

SATURDAY, Feb. 29, 2020 — Three new U.S. coronavirus cases of unknown origin, confirmed in California, Oregon and Washington state, are fueling fears of “community spread” of COVID-19 among Americans. The news came as the World Health Organization on Friday raised its risk assessment of the new coronavirus’ spread to “very high,” with cases of… Read More »

U.S. House Passes Drug Pricing Bill

Dec. 13, 2019 — A U.S. House Democrat bill that would give Medicare the authority to negotiate prescription drug prices and provide new benefits for seniors was passed Thursday in a 230-192 vote along party lines. However, the bill has no chance of being passed by the Republican-controlled Senate and the White House has threatened… Read More »